LOGIN
Ketorolac vs. Depomedrol Injections for Subacromial Impingement
April 2022
Ketorolac vs. Depomedrol Injections for Subacromial Impingement
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Outcomes of ketorolac versus depomedrol infiltrations for subacromial impingement syndrome: a randomized controlled trial
Musculoskelet Surg . 2022 Mar;106(1):29-34.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seventy patients with subacromial impingement syndrome were randomized to receive a subacromial depomedrol injection (n=35) or a subacromial ketorolac injection (n=35). The outcomes of interest included pain, function and range of motion at one and three month follow-up. There was no significant differences in pain as measured by a visual analogue scale. No differences in function between the two ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.